Myopericytoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:289685D21.9
Who is this for?
Show terms as
16Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Myopericytoma is a rare benign soft tissue tumor that arises from perivascular myoid cells (pericytes), which are cells that normally surround small blood vessels. This tumor belongs to the family of perivascular tumors, which also includes myofibroma and glomus tumors. Myopericytomas most commonly present as a slow-growing, painless, well-circumscribed nodule in the subcutaneous tissue or dermis of the extremities, particularly the lower limbs. They can also occur in other locations including the head, neck, and trunk. The tumors are typically solitary, although rare cases of multifocal myopericytomas have been reported. Histologically, myopericytomas are characterized by a concentric perivascular proliferation of oval to spindle-shaped myoid cells arranged around thin-walled blood vessels. The tumor cells express smooth muscle actin, reflecting their pericytic origin. While the vast majority of myopericytomas are benign, exceedingly rare malignant variants have been described in the literature, which may exhibit infiltrative growth, nuclear atypia, increased mitotic activity, and potential for metastasis. The primary treatment for myopericytoma is complete surgical excision, which is generally curative for benign lesions. Local recurrence is uncommon after adequate resection. No specific systemic therapy is typically required for benign myopericytomas. For the rare malignant cases, wider excision and close follow-up are recommended, though standardized treatment protocols are lacking due to the extreme rarity of malignant transformation. Prognosis for typical benign myopericytoma is excellent.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Myopericytoma.

View clinical trials →

No actively recruiting trials found for Myopericytoma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Myopericytoma community →

Specialists

16 foundView all specialists →
GL
Gui Liu
HONOLULU, HI
Specialist
1 Myopericytoma publication
MW
Michelle Wu
Specialist
1 Myopericytoma publication
CL
Cheng Z Liu
Specialist
1 Myopericytoma publication
TB
Tamar C Brandler
NEW BRUNSWICK, NJ
Specialist
1 Myopericytoma publication
MT
Marcus Wei Ping Tan
Specialist
1 Myopericytoma publication
AT
Adriel You Wei Tay
Specialist
1 Myopericytoma publication
KC
Khong Yik Chew
Specialist
1 Myopericytoma publication
EY
Eng Meng Nicholas Yeo
Specialist
1 Myopericytoma publication
NR
Nicholas J Roig
BOSTON, MA
Specialist
1 Myopericytoma publication
BW
Bin Wei
MINNEAPOLIS, MN
Specialist
1 Myopericytoma publication
HQ
Hongzhi Quan
Specialist
1 Myopericytoma publication
GM
Gianluca Marcaccini
Specialist
1 Myopericytoma publication
IS
Ishith Seth
Specialist
1 Myopericytoma publication
OH
Osvaldo Hernandez
STOCKTON, CA
Specialist
1 Myopericytoma publication
PT
Po Yin Tang
PHILADELPHIA, PA
Specialist
1 Myopericytoma publication
EP
elif polat
Specialist
PI on 1 active trial5 Myopericytoma publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Myopericytoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open MyopericytomaForum →

No community posts yet. Be the first to share your experience with Myopericytoma.

Start the conversation →

Latest news about Myopericytoma

No recent news articles for Myopericytoma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Myopericytoma

What is Myopericytoma?

Myopericytoma is a rare benign soft tissue tumor that arises from perivascular myoid cells (pericytes), which are cells that normally surround small blood vessels. This tumor belongs to the family of perivascular tumors, which also includes myofibroma and glomus tumors. Myopericytomas most commonly present as a slow-growing, painless, well-circumscribed nodule in the subcutaneous tissue or dermis of the extremities, particularly the lower limbs. They can also occur in other locations including the head, neck, and trunk. The tumors are typically solitary, although rare cases of multifocal myope

How is Myopericytoma inherited?

Myopericytoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Myopericytoma typically begin?

Typical onset of Myopericytoma is adult. Age of onset can vary across affected individuals.

Which specialists treat Myopericytoma?

16 specialists and care centers treating Myopericytoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.